Development and Validation of a Short Tool to Assess the Awareness of Pregnancy-induced Hypertension
1 other identifier
observational
135
1 country
1
Brief Summary
Background: Pregnancy-induced hypertension (PIH) is responsible for most perinatal and fetal mortality. Few programs are patient-centered during pregnancy, increasing the risks of misinformation and misconceptions among pregnant women and, as a result, malpractices. Objective: This study aims to develop and validate a form to assess the knowledge and attitudes of pregnant women about PIH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFirst Submitted
Initial submission to the registry
May 4, 2023
CompletedFirst Posted
Study publicly available on registry
May 15, 2023
CompletedMay 15, 2023
May 1, 2023
4 months
May 4, 2023
May 12, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Awareness of hypertensive disorders of pregnancy by developing a 25-item questionnaire
Thirty-six statements were initially provided to which women had to answer either ''yes'', ''No'' or ''I don't Know''. Out of these statements, 25 were retained due to positive inter-item correlation (15 knowledge statements and 10 behavior statements), and the other statements were eliminated one by one after testing for reliability and computing the effect of each statement on the internal consistency.
6 months
Interventions
A short 25-item tool was developed and can be applied in clinics to assess the awareness of pregnancy hypertension.
Eligibility Criteria
Pregnant women were targeted from five obstetrics and gynecology clinics.
You may qualify if:
- Participants were asked to participate in the study with no criteria based on race, ethnicity, or gestational age.
You may not qualify if:
- Those with a history of hypertension or pre-eclampsia were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Georges Hatemlead
Study Sites (1)
Lebanese University Faculty of pharmacy
Beirut, 0000, Lebanon
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor-Principal investigator
Study Record Dates
First Submitted
May 4, 2023
First Posted
May 15, 2023
Study Start
November 7, 2021
Primary Completion
February 27, 2022
Study Completion
June 30, 2022
Last Updated
May 15, 2023
Record last verified: 2023-05